What is he best known for?
The fields of study he is best known for:
- Enzyme
- Organic chemistry
- Gene
Stereochemistry, Structure–activity relationship, Virology, Virus and Chemical synthesis are his primary areas of study.
The study incorporates disciplines such as Biological activity and Potency in addition to Stereochemistry.
His Structure–activity relationship research is multidisciplinary, incorporating elements of IC50, Benzimidazole and Anti hiv activity.
His Virology research includes elements of Mutation, Efavirenz, Transactivation and Mechanism of action.
His Virus research includes themes of Integrase and Molecular biology.
His study in Chemical synthesis is interdisciplinary in nature, drawing from both Lactam, Reverse-transcriptase inhibitor, Thiadiazoles, Bicyclic molecule and Enzyme inhibitor.
His most cited work include:
- Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later (262 citations)
- Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. (231 citations)
- Synthesis and antiviral activity of new pyrazole and thiazole derivatives (209 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Stereochemistry, Reverse transcriptase, Virology, Structure–activity relationship and In vitro.
The concepts of his Stereochemistry study are interwoven with issues in Combinatorial chemistry and Chemical synthesis.
His studies examine the connections between Chemical synthesis and genetics, as well as such issues in Reverse-transcriptase inhibitor, with regards to Enzyme inhibitor and Nucleotidyltransferase.
Christophe Pannecouque has included themes like Nevirapine, Mutant and Enzyme in his Reverse transcriptase study.
His research links Integrase with Virology.
His studies link Cell culture with Structure–activity relationship.
He most often published in these fields:
- Stereochemistry (55.43%)
- Reverse transcriptase (32.76%)
- Virology (22.10%)
What were the highlights of his more recent work (between 2015-2021)?
- Stereochemistry (55.43%)
- Reverse transcriptase (32.76%)
- Mutant (9.33%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Stereochemistry, Reverse transcriptase, Mutant, Etravirine and Combinatorial chemistry.
His study in Stereochemistry focuses on Molecular model in particular.
His Reverse transcriptase research is multidisciplinary, relying on both Structure–activity relationship, Pyrimidine and Enzyme.
His Enzyme study incorporates themes from In vitro, Viral replication and Virology.
In his research on the topic of Mutant, Drug resistance is strongly related with Mutation.
His work carried out in the field of Etravirine brings together such families of science as Rilpivirine, Bioavailability, Efavirenz, Nevirapine and Drug discovery.
Between 2015 and 2021, his most popular works were:
- Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends (157 citations)
- Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles. (67 citations)
- Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks (50 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Organic chemistry
- Gene
His scientific interests lie mostly in Stereochemistry, Reverse transcriptase, Diarylpyrimidines, Combinatorial chemistry and Structure–activity relationship.
His Stereochemistry research incorporates themes from Mutant and Cytotoxicity.
Christophe Pannecouque combines subjects such as Potency and Pyrimidine with his study of Reverse transcriptase.
Christophe Pannecouque has researched Diarylpyrimidines in several fields, including Anti hiv and Efavirenz.
His research integrates issues of Cancer cell, Molecular network and Combinatorial Chemistry Techniques in his study of Structure–activity relationship.
His Nucleoside Reverse Transcriptase Inhibitor research integrates issues from Hiv treatment, Virus, Virology and Infectious agent.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
